Rifabutin clinical trials
Also written Mycobutin.
How each study uses Rifabutin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Rifabutin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 23 Dec 1992 · MYCOBUTIN · NDA 050689 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
34 studies that test it; most in 1999 (3)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1995 | 1 |
| 1998 | 1 |
| 1999 | 3 |
| 2000 | 1 |
| 2003 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 15 · Other 31
Pharmacia (6) · Centers for Disease Control and Prevention (5) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · The University of Texas Health Science Center at Tyler (3) · ViiV Healthcare (2) · Boehringer Ingelheim (2) · Shanghai Jiao Tong University School of Medicine (1) · BeiGene (1)
Often tested with
Tested in the same studies.
Clarithromycin (4) · Ritonavir (4) · Bedaquiline (3) · Azithromycin (3) · Moxifloxacin (2) · Lopinavir-ritonavir drug combination (2) · Nevirapine (2) · Efavirenz (2)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2, 2 in phase 3
Studies that test Rifabutin, phase 3 first.
- Nov 2026Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIRPhase 3 · Tourcoing Hospital
- Dec 2026Short-course Regimens for the Treatment of Pulmonary TuberculosisPhase 2/3 · Centers for Disease Control and Prevention
Studies
Open first, then newest update. How each study uses Rifabutin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 46
- The Effect of Rifabutin in Mycobacterium Abscessus With Inducible Clarithromycin ResistanceRecruitingPhase 4National Taiwan University HospitalNCT07514364Written as RifabutinHow we know
- Finding the Optimal Regimen for Mycobacterium Abscessus TreatmentRecruitingPhase 2/3The University of QueenslandNCT04310930Written as RifabutinHow we know
- Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIRRecruitingPhase 3Tourcoing HospitalNCT04672525Written as RifabutinHow we know
- Short-course Regimens for the Treatment of Pulmonary TuberculosisActive, not recruitingPhase 2/3Centers for Disease Control and PreventionNCT05766267Written as RifabutinHow we know
- Rescue Therapy for Helicobacter Pylori InfectionCompletedPhase 4Shanghai Jiao Tong University School of MedicineNCT05874544Written as RifabutinHow we know
- The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy MalesCompletedPhase 1BeiGeneNCT04470908Written as RifabutinHow we know
- Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/IvacaftorCompletedPhase 4University of Southern CaliforniaNCT04840862Written as Rifabutin 300mgHow we know
- The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected PatientsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00001030Written as RifabutinHow we know
- Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine MetabolitesCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000826Written as RifabutinHow we know
- Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative AdultsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000877Written as RifabutinHow we know
- Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart DiseaseTerminatedPhase 2Cadrock Pty. Ltd.NCT03618108Written as Rifabutin Oral CapsuleHow we know
- Effectiveness of Rifabutin for Treatment of Helicobacter PyloriStatus unknownPhase 3Rabin Medical CenterNCT04652284Written as RifabutinHow we know
- Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.Status unknownPhase 3University of BariNCT04107194Written as Rifabutin 150 MGHow we know
- Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy SubjectsCompletedPhase 1ViiV HealthcareNCT03149848Written as RifabutinHow we know
- A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of MaravirocCompletedPhase 1Ottawa Hospital Research InstituteNCT01894776Written as RifabutinHow we know
- Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice WeeklyCompletedPhase 2The HIV Netherlands Australia Thailand Research CollaborationNCT02415985Written as RifabutinHow we know
- Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.Status unknownPhase 4Konstantopoulio-Patission General Hospital of Nea IoniaNCT04090021Written as Rifabutin 150 MGHow we know
- Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With TuberculosisStatus unknownNot applicableShanghai Public Health Clinical CenterNCT03478033Written as RifabutinHow we know
- Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIVTerminatedPhase 2Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsNCT01601626Written as RifabutinHow we know
- Drug-drug Interaction (DDI) RifabutinCompletedPhase 1ViiV HealthcareNCT02138084Written as RifabutinHow we know
See all 46 studies that test Rifabutin →
Given beside what is tested · 9 — Rifabutin is usual care or a partner of the new treatment
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialNot yet recruitingPhase 2The University of QueenslandNCT07485010Written as RifabutinHow we know
- A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy AdultsCompletedPhase 1ViiV HealthcareNCT07066722Written as RifabutinHow we know
- A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)CompletedPhase 1Merck Sharp & Dohme LLCNCT07199452Written as RifabutinHow we know
- Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus LevelsTerminatedPhase 1Gilead SciencesNCT05458102Written as RifabutinHow we know
- A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and RifabutinCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT03891901Written as RifabutinHow we know
- Assessing PA-824 for Tuberculosis (the APT Trial)CompletedPhase 2Johns Hopkins UniversityNCT02256696Written as RifabutinHow we know
- Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other DrugsCompletedPhase 1ViriomNCT03709355Written as RifabutinHow we know
- Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female VolunteersCompletedPhase 1ViiV HealthcareNCT01231542Written as RifabutinHow we know
- Interaction of Buprenorphine With HIV Medications and Tuberculosis MedicationsCompletedPhase 1University of California, San FranciscoNCT00877591Written as RifabutinHow we know
As the comparator · 1 — what is tested is compared with Rifabutin
Codes
What other systems call Rifabutin · ClinicalTrials.gg INT008615
- MeSH (NLM) D017828RifabutinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1W306TDA6SRIFABUTINConfirmed FDA, NLM, Wikidata
- RxNorm 55672Confirmed FDA, Wikidata
- Wikidata Q1135705rifabutinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1408RifabutinOne source FDA
- DrugBank DB00615One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017828 | Rifabutin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1W306TDA6S | RIFABUTIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 55672 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1135705 | rifabutin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1408 | Rifabutin | One source FDA |
| DrugBank | DB00615 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.